Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference
Pacira BioSciences (NASDAQ:PCRX) will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026 at 2:30 PM ET in Miami.
Rhea-AI Summary
Pacira BioSciences (NASDAQ:PCRX) will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026 at 2:30 PM ET in Miami. Live audio will stream on the company Events page and a replay will be available for two weeks.
Positive
- None.
Negative
- None.
Details
News Market Reaction – PCRX
In the Mar 4 session, PCRX gained 3.44%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference edition
- 28th
- Barclays Annual Global Healthcare Conference
- Event time
- 2:30 PM ET
- Fireside chat time on March 11, 2026
- Event date
- March 11, 2026
- Scheduled conference fireside chat
- Replay duration
- Two weeks
- Webcast replay availability after the event
- Current price
- $22.10
- Pre-news market context for PCRX
- 52-week range
- $18.80–$27.64
- Low and high prior to this news
- Price vs 52-week high
- -20.04%
- Distance below 52-week high before the conference news
- Short interest
- 21.51%
- Short interest as percent of float
Historical Context
-
Real-world IGOR registry data presented for EXPAREL and iovera° knee treatments.
-
Q4 and 2025 results with revenue growth, profitability and 2026 guidance disclosed.
-
Announcement of timing and access details for 2025 results conference call.
-
NOPAIN Act survey data highlighting increased non-opioid use and reduced opioid prescribing.
-
Inducement stock options and RSUs granted under Nasdaq Listing Rule 5635(c)(4).
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRISBANE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference at 2:30 PM ET on Wednesday, March 11, 2026 in Miami. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.
About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera®º, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing a pipeline of clinical-stage assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit www.pacira.com.
Company Contact: Pacira BioSciences, Inc. Christian Pedetti (973) 254-4387 Christian.pedetti@pacira.com